538 related articles for article (PubMed ID: 20067962)
1. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects.
Dasu MR; Devaraj S; Park S; Jialal I
Diabetes Care; 2010 Apr; 33(4):861-8. PubMed ID: 20067962
[TBL] [Abstract][Full Text] [Related]
2. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state.
Devaraj S; Dasu MR; Rockwood J; Winter W; Griffen SC; Jialal I
J Clin Endocrinol Metab; 2008 Feb; 93(2):578-83. PubMed ID: 18029454
[TBL] [Abstract][Full Text] [Related]
3. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation.
Dasu MR; Devaraj S; Zhao L; Hwang DH; Jialal I
Diabetes; 2008 Nov; 57(11):3090-8. PubMed ID: 18650365
[TBL] [Abstract][Full Text] [Related]
4. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling.
Piao W; Song C; Chen H; Diaz MA; Wahl LM; Fitzgerald KA; Li L; Medvedev AE
J Leukoc Biol; 2009 Oct; 86(4):863-75. PubMed ID: 19656901
[TBL] [Abstract][Full Text] [Related]
5. Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes.
Devaraj S; Tobias P; Jialal I
Cytokine; 2011 Sep; 55(3):441-5. PubMed ID: 21498084
[TBL] [Abstract][Full Text] [Related]
6. Dual regulation of osteopontin production by TLR stimulation in dendritic cells.
Salvi V; Scutera S; Rossi S; Zucca M; Alessandria M; Greco D; Bosisio D; Sozzani S; Musso T
J Leukoc Biol; 2013 Jul; 94(1):147-58. PubMed ID: 23610145
[TBL] [Abstract][Full Text] [Related]
7. A toll-like receptor 2 pathway regulates the Ppargc1a/b metabolic co-activators in mice with Staphylococcal aureus sepsis.
Sweeney TE; Suliman HB; Hollingsworth JW; Welty-Wolf KE; Piantadosi CA
PLoS One; 2011; 6(9):e25249. PubMed ID: 21966468
[TBL] [Abstract][Full Text] [Related]
8. Pellino-1 Positively Regulates Toll-like Receptor (TLR) 2 and TLR4 Signaling and Is Suppressed upon Induction of Endotoxin Tolerance.
Murphy M; Xiong Y; Pattabiraman G; Qiu F; Medvedev AE
J Biol Chem; 2015 Jul; 290(31):19218-32. PubMed ID: 26082489
[TBL] [Abstract][Full Text] [Related]
9. Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue.
Vitseva OI; Tanriverdi K; Tchkonia TT; Kirkland JL; McDonnell ME; Apovian CM; Freedman J; Gokce N
Obesity (Silver Spring); 2008 May; 16(5):932-7. PubMed ID: 18292749
[TBL] [Abstract][Full Text] [Related]
10. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling.
Wang S; Schmaderer C; Kiss E; Schmidt C; Bonrouhi M; Porubsky S; Gretz N; Schaefer L; Kirschning CJ; Popovic ZV; Gröne HJ
Dis Model Mech; 2010; 3(1-2):92-103. PubMed ID: 20038715
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice.
Dasu MR; Park S; Devaraj S; Jialal I
Endocrinology; 2009 Aug; 150(8):3457-64. PubMed ID: 19389833
[TBL] [Abstract][Full Text] [Related]
12. Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors.
Dasu MR; Jialal I
Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E145-54. PubMed ID: 20959532
[TBL] [Abstract][Full Text] [Related]
13. An alternative model for type I interferon induction downstream of human TLR2.
Oosenbrug T; van de Graaff MJ; Haks MC; van Kasteren S; Ressing ME
J Biol Chem; 2020 Oct; 295(42):14325-14342. PubMed ID: 32796029
[TBL] [Abstract][Full Text] [Related]
14. A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling.
Nilsen NJ; Vladimer GI; Stenvik J; Orning MP; Zeid-Kilani MV; Bugge M; Bergstroem B; Conlon J; Husebye H; Hise AG; Fitzgerald KA; Espevik T; Lien E
J Biol Chem; 2015 Feb; 290(6):3209-22. PubMed ID: 25505250
[TBL] [Abstract][Full Text] [Related]
15. The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals.
Williams KL; Lich JD; Duncan JA; Reed W; Rallabhandi P; Moore C; Kurtz S; Coffield VM; Accavitti-Loper MA; Su L; Vogel SN; Braunstein M; Ting JP
J Biol Chem; 2005 Dec; 280(48):39914-24. PubMed ID: 16203735
[TBL] [Abstract][Full Text] [Related]
16. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
[TBL] [Abstract][Full Text] [Related]
17. TLR4-HMGB1-, MyD88- and TRIF-dependent signaling in mouse intestinal ischemia/reperfusion injury.
Wang J; He GZ; Wang YK; Zhu QK; Chen W; Guo T
World J Gastroenterol; 2015 Jul; 21(27):8314-25. PubMed ID: 26217083
[TBL] [Abstract][Full Text] [Related]
18. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta.
Oshiumi H; Sasai M; Shida K; Fujita T; Matsumoto M; Seya T
J Biol Chem; 2003 Dec; 278(50):49751-62. PubMed ID: 14519765
[TBL] [Abstract][Full Text] [Related]
19. Variations within Toll-like receptor (TLR) and TLR signaling pathway-related genes and their synergistic effects on the risk of Guillain-Barré syndrome.
Dutta D; Nagappa M; Sreekumaran Nair BV; Das SK; Wahatule R; Sinha S; Vasanthapuram R; Taly AB; Debnath M
J Peripher Nerv Syst; 2022 Jun; 27(2):131-143. PubMed ID: 35138004
[TBL] [Abstract][Full Text] [Related]
20. High mobility group box 1/Toll-like receptor danger signaling increases brain neuroimmune activation in alcohol dependence.
Crews FT; Qin L; Sheedy D; Vetreno RP; Zou J
Biol Psychiatry; 2013 Apr; 73(7):602-12. PubMed ID: 23206318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
